CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +141,000 | 2,400,598 | ||
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +186,000 | 2,586,598 | ||
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +100,000 | 2,686,598 | ||
| 2025-02-11 | Gabay Avraham Chief Financial Officer | Grant or award | +34,000 | 392,040 | ||
| 2025-02-11 | Gabay Avraham Chief Financial Officer | Grant or award | +42,000 | 434,040 | ||
| 2025-01-02 | Kidron Miriam Chief Scientific Officer | Grant or award | +207,000 | 1,000,666 | ||
| 2025-01-02 | KIDRON NADAV President and CEO | Grant or award | +433,500 | 2,259,598 | ||
| 2025-01-02 | Gabay Avraham Chief Financial Officer | Grant or award | +188,000 | 358,040 | ||
| 2025-01-02 | Hexter Joshua COO & CBO | Grant or award | +194,500 | 706,333 | ||
| 2024-11-07 | Gabay Avraham Chief Financial Officer | Grant or award | +30,000 | 170,040 | ||
| 2024-11-07 | KIDRON NADAV President and CEO | Grant or award | +45,000 | 1,826,098 | ||
| 2024-11-07 | Kidron Miriam Chief Scientific Officer | Grant or award | +30,000 | 793,666 | ||
| 2024-11-07 | Hexter Joshua COO & CBO | Grant or award | +30,000 | 511,833 | ||
| 2024-06-21 | Gabay Avraham Chief Financial Officer | Grant or award | +140,040 | 0 | ||
| 2024-06-06 | Reznick Yehuda Director | Grant or award | +760 | 30,560 | ||
| 2024-04-17 | Reznick Yehuda Director | Grant or award | +29,800 | 29,800 | ||
| 2024-01-30 | Aghion Daniel Director | Grant or award | +3,750 | 38,820 | ||
| 2024-01-04 | Kidron Miriam Chief Scientific Officer | Grant or award | +295,500 | 763,666 | ||
| 2024-01-04 | KIDRON NADAV President and CEO | Grant or award | +329,000 | 1,781,098 | ||
| 2024-01-04 | Hexter Joshua COO & CBO | Grant or award | +180,500 | 481,833 |
Page 5 of 9 · 170 trades